307
Participants
Start Date
December 22, 2016
Primary Completion Date
November 22, 2018
Study Completion Date
November 1, 2023
Isatuximab
Pharmaceutical form: solution for infusion Route of administration: intravenous
Pomalidomide
Pharmaceutical form: capsule Route of administration: oral
Dexamethasone
Pharmaceutical form: tablets or solution for infusion Route of administration: oral or intravenous
Investigational Site Number : 1580001, Taipei
Investigational Site Number : 1580003, Taoyuan District
Investigational Site Number : 1580004, Kaohsiung City
Investigational Site Number : 6200002, Lisbon
Investigational Site Number : 3480001, Budapest
Investigational Site Number : 0560002, Brussels
Investigational Site Number : 3480003, Budapest
Investigational Site Number : 5540001, Takapuna
Investigational Site Number : 5540002, Auckland
Investigational Site Number : 0560003, Antwerp
Investigational Site Number : 0360004, St Leonards
Investigational Site Number : 0360001, Waratah
Investigational Site Number : 0360005, Melbourne
Investigational Site Number : 0560001, Leuven
Investigational Site Number : 0360002, Melbourne
Investigational Site Number : 0360006, Richmond
Investigational Site Number : 5540003, Hamilton
Investigational Site Number : 3480002, Debrecen
Investigational Site Number : 6200001, Porto
Investigational Site Number : 0560004, Ghent
Investigational Site Number : 5540004, Dunedin
Investigational Site Number : 2080002, Aalborg
Investigational Site Number : 3800003, Torino
Investigational Site Number : 3000005, Athens
Investigational Site Number : 3000001, Athens
Investigational Site Number : 2030003, Prague
Investigational Site Number : 2500008, Caen
Investigational Site Number : 7240005, Santiago de Compostela
Investigational Site Number : 3800008, Genova
Investigational Site Number : 3800007, Milan
Investigational Site Number : 3800002, Milan
Investigational Site Number : 2500009, Dijon
Investigational Site Number : 4100006, Incheon
Investigational Site Number : 3000004, Pátrai
Investigational Site Number : 7240003, Madrid
Investigational Site Number : 7240002, Pamplona
Investigational Site Number : 2500001, Toulouse
BRCR Medical Center Inc. Site Number : 8400002, Plantation
Investigational Site Number : 2500005, Pessac
Investigational Site Number : 7920005, Istanbul
Investigational Site Number : 2500019, Montpellier
Investigational Site Number : 7920006, Istanbul
Investigational Site Number : 7920003, Istanbul
Investigational Site Number : 2500014, Rennes
Investigational Site Number : 7920008, Izmir
Investigational Site Number : 3800006, Padua
Investigational Site Number : 7920010, Izmir
Investigational Site Number : 7240004, Salamanca
Investigational Site Number : 2500012, Tours
Investigational Site Number : 7920009, Kayseri
Investigational Site Number : 2500017, Grenoble
Investigational Site Number : 7240006, Santander
Investigational Site Number : 3800001, Bologna
Investigational Site Number : 1580002, Taichung
Investigational Site Number : 7920007, Kocaeli
Investigational Site Number : 2500002, Nantes
Investigational Site Number : 2030004, Hradec Králové
Investigational Site Number : 3800009, Florence
Investigational Site Number : 2500025, Reims
Investigational Site Number : 2500018, Vandœuvre-lès-Nancy
Investigational Site Number : 3000003, Thessaloniki
Investigational Site Number : 4100007, Hwasun-gun
Investigational Site Number : 2500003, Lille
Investigational Site Number : 2030005, Brno
Investigational Site Number : 2500021, Bayonne
Investigational Site Number : 2500004, Pierre-Bénite
Investigational Site Number : 2030002, Ostrava - Poruba
Investigational Site Number : 2500015, Paris
Investigational Site Number : 2500016, Paris
Investigational Site Number : 2030001, Olomouc
Investigational Site Number : 7030001, Bratislava
Investigational Site Number : 2500013, La Roche-sur-Yon
Investigational Site Number : 2500007, Poitiers
Investigational Site Number : 2500023, Limoges
Investigational Site Number : 3800010, Catania
Investigational Site Number : 7520004, Luleå
Investigational Site Number : 6430004, Moscow
Investigational Site Number : 6430001, Moscow
Investigational Site Number : 6430002, Moscow
Dana Farber Site Number : 8400006, Boston
Investigational Site Number : 1240001, Montreal
Investigational Site Number : 1240004, Montreal
Investigational Site Number : 1240005, Sherbrooke
Investigational Site Number : 2760001, Leipzig
Investigational Site Number : 3000002, Athens
Investigational Site Number : 3800004, Terni
Investigational Site Number : 3920001, Nagoya
Investigational Site Number : 3920005, Shibukawa-shi
Investigational Site Number : 3920004, Sapporo
Investigational Site Number : 3920006, Kyoto
Investigational Site Number : 3920008, Suwa-shi
Investigational Site Number : 3920003, Okayama
Investigational Site Number : 3920007, Sunto-gun
Investigational Site Number : 3920002, Shibuya-ku
Investigational Site Number : 5780001, Oslo
Investigational Site Number : 6160005, Krakow
Investigational Site Number : 6160003, Lublin
Investigational Site Number : 6160001, Warsaw
Investigational Site Number : 6160002, Chorzów
Investigational Site Number : 6200004, Coimbra
Investigational Site Number : 4100001, Seoul
Investigational Site Number : 4100002, Seoul
Investigational Site Number : 4100005, Seoul
Investigational Site Number : 7240001, Barcelona
Investigational Site Number : 7520005, Uddevalla
Investigational Site Number : 7920001, Ankara
Investigational Site Number : 7920002, Antalya
Investigational Site Number : 7920004, Istanbul
Investigational Site Number : 8260002, London
Investigational Site Number : 8260003, London
Investigational Site Number : 8260001, London
Lead Sponsor
Sanofi
INDUSTRY